Labshake search
Citations for Stemcell Technologies :
701 - 750 of 1648 citations for Mono 2 Ethyl 5 Hydroxyhexyl Phthalate 13C4 99% Dehp Metabolite Ix 100 Ug Ml In Mtbe since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2019Quote: ... 30ng/ml FGF2 and collagen (Stem Cell Technologies) at a ratio of 1:3 (collagen/medium) ...
-
bioRxiv - Immunology 2020Quote: ... Human Recombinant IFNγ (10ng/mL, StemCell Technologies 78020) was added to the media for a period of 60 minutes ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml GDNF (Stem Cell Technologies Cat # 78058), 20ng/ml NT-3 (Stem Cell Technologies Cat # 78074) ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml BDNF (Stem Cell Technologies Cat # 78005), 20ng/ml GDNF (Stem Cell Technologies Cat # 78058) ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 100μg/mL SCF (StemCell Technologies 78062), 100μg/mL TPO (StemCell Technologies 78210.1) ...
-
bioRxiv - Immunology 2021Quote: ... and 0.1 U/ml dispase (STEMCELL Technologies, #07913) in DMEM supplemented with 10% FCS ...
-
bioRxiv - Cancer Biology 2022Quote: ... incubated with 1U/ml dispase (STEMCELL Technologies# 07923) supplemented with 0.05 mg/ml liberase (Sigma-Aldrich# 05401127001 ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Cancer Biology 2024Quote: ... 25 ng/mL hSCF (Stem Cell Technologies 78062), 25 ng/mL Flt3 (Stem Cell Technologies 78009 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 25 ng/mL Flt3 (Stem Cell Technologies 78009) and 10 ng/mL TPO (STEMCELL Technologies 78210.1) ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 10 ng/mL TPO (STEMCELL Technologies 78210.1), 10 ng/mL EPO (STEMCELL Technologies 78007) ...
-
bioRxiv - Neuroscience 2024Quote: ... rhEGF (10 ng/ml, Stem Cell Technologies #E9644), bFGF (10 ng/mL ...
-
bioRxiv - Neuroscience 2024Quote: ... bFGF (10 ng/mL, Stem Cell Technologies #02634), N2-hormone mix (Thermo Fischer ...
-
bioRxiv - Neuroscience 2024Quote: ... and 0.02 µg/mL EGF (StemCell Technologies, #78006.1). To each well ...
-
bioRxiv - Cancer Biology 2024Quote: ... 100ng/mL r-Noggin (Stem Cell Technologies, 78060), 5ng/mL FGF-10 (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5ng/mL FGF-10 (Stem Cell Technologies, 78037), 37.5 ng/mL Heregulin B-1 (Peprotech ...
-
bioRxiv - Cancer Biology 2024Quote: ... heparin (2µg/ml, Stem Cell Technologies Cat. #07980), mEGF (20ng/ml ...
-
bioRxiv - Cancer Biology 2024Quote: ... and heparin (10 ng/ml, Stemcell Technologies, 07980). Doubling times were computed using ...
-
bioRxiv - Immunology 2023Quote: ... 1 µg/ml low density lipoprotein (Stemcell Technologies), 60 µM ascorbic acid (Sigma) ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... recombinant EGF (20 ng/mL, human, STEMCELL Technologies) and antibiotic antimycotic solution (100x ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 4 µg/mL heparin (STEMCELL Technologies), 480 ng/mL hydrocortisone ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/mL hrM-CSF (Stem Cell Technologies) and 100 nM β-Estradiol (Sigma−Aldrich) ...
-
bioRxiv - Immunology 2023Quote: ... IGF-1 (40 ng/mL; Stem Cell Technologies), cholesterol-rich lipids (40 µg/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Immunology 2023Quote: ... and 20 ng/ml GM-CSF (StemCell Technologies) for 8 days at 37°C ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... recombinant bFGF (20 ng/mL, human, STEMCELL Technologies), recombinant EGF (20 ng/mL ...
-
bioRxiv - Neuroscience 2023Quote: ... on 10 µg/mL Vitronectin XF (StemCell Technologies) coated plates ...
-
bioRxiv - Immunology 2023Quote: ... and 0.3mg/mL Collagenase IV (StemCell Technologies, #07427) for digestion at 37°C with gentle shaking ...
-
bioRxiv - Bioengineering 2023Quote: ... 1 mL gentle cell dissociation reagent (STEMCELL Technologies) was added to each well ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...
-
bioRxiv - Microbiology 2023Quote: ... using SepMate 50 ml tubes (StemCell Technologies, USA) and then directly used or frozen in fetal bovine serum (FBS ...
-
bioRxiv - Cancer Biology 2024Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Cancer Biology 2024Quote: ... 4 µg/mL heparin (StemCell Technologies, Vancouver, Canada), and 100 U/mL penicillin-streptomycin (Life Technologies ...
-
bioRxiv - Bioengineering 2024Quote: ... 50ng/ml of Activin A (Stemcell Technologies, #78132.2), and 10ng/ml of Bone Morphogenic Protein-4 (BMP-4 ...
-
bioRxiv - Microbiology 2024Quote: ... and 50 ml SepMate tubes (STEM CELL Technologies) according to the manufacturer’s protocol ...
-
bioRxiv - Cancer Biology 2020Quote: ... unfractionated nucleated BM cells (5×105) were suspended in methylcellulose medium (M3231, StemCell Technologies) with 0.1 ...
-
bioRxiv - Cancer Biology 2020Quote: ... unfractionated nucleated BM cells (5×105) were suspended in methylcellulose medium (M3231, StemCell Technologies) with 0.01 ng/ml murine GM-CSF (Peprotech ...
-
bioRxiv - Biochemistry 2022Quote: ... Cells were passaged every 5-7 days using ReLeSR (STEMCELL Technologies, Vancouver, BC, Canada) and maintained within passages 20 to 50.
-
bioRxiv - Neuroscience 2019Quote: ... Cultures were maintained at 37°C at 5% CO2 in BrainPhys media (StemCell Technologies) without phenol red supplemented with SM1 (StemCell Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... coiled-coil containing protein kinase (ROCK) inhibitor (5 μM, StemCell Technologies, Vancouver, BC, Canada). Until 95% confluency was reached ...
-
bioRxiv - Cell Biology 2019Quote: ... Routine passaging every 4-5 days was performed using ReLeSR (Cat. # 05873; STEMCELL Technologies) according to manufacturer’s instructions ...
-
bioRxiv - Neuroscience 2023Quote: ... iPSCs were passaged every 5-6 days using ReLeSR dissociation reagent (STEMCELL Technologies, 05872) and used for hematopoietic stem cell differentiation with STEMdiff Hematopoietic kit (STEMCELL Technologies ...
-
bioRxiv - Molecular Biology 2022Quote: ... at 37°C and passaged every 5-6 days using ReLeSR (Stem Cell Technologies).
-
bioRxiv - Developmental Biology 2024Quote: ... iPSCs lines were passaged every 5 days using Gentle Cell Dissociation Reagent (Stemcell Technologies) and plated in mTesr1 in the presence of 10 uM Y-27632 (Stemcell Technologies) ...
-
bioRxiv - Cell Biology 2023Quote: ... Routine passaging was performed every 4-5 days using ReLeSR (Cat. # 05873; STEMCELL Technologies) according to manufacturer’s instructions in E8/VTN or by treatment with Collagenase IV (Cat ...
-
bioRxiv - Genetics 2024Quote: ... Cells were differentiated for 5 days with the STEMDiff hepatocyte kit (Stem Cell Technologies), according to the manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2024Quote: ... followed by 48 hours of 5 µM IWR-1-endo (Stem Cell Technologies 72562) on day 4 ...
-
bioRxiv - Molecular Biology 2021Quote: ... the pooled samples were diluted 1:1 with PBS+2% FBS and loaded into SepMate-15™ tubes with 4.5 mL of Lymphoprep™ with a density of 1.077g/mL (StemCell Technologies). Cells were centrifuged at 1200x g for 20min at 4°C ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...